Pages
Vote for naming Bakewell’s new NHS health hub
https://dchs.nhs.uk/news/vote-naming-bakewells-new-nhs-health-hub
Meet your LGBT+ advocates
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/meet-your-lgbt-advocates
Bridging the healthcare access gap for people with disabilities
A NEW initiative to encourage more healthcare and/or non-clinical staff to take up sign language as an extra language and skill, is now available locally.
Mayor of Chesterfield opens new diagnostic centre at Walton Hospital
https://dchs.nhs.uk/news/mayor-chesterfield-opens-new-diagnostic-centre-walton-hospital
Files
APPENDIX 3 Paternity Partner Leave Flow Chart for Managers.docx
Organisational strategy - Bitesize slides - Focus on the Future
Organisational strategy - Bitesize slides - Focus on the Future
Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)
The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.
Employee online user guide - temporary staffing.pdf
Stop Think SHARP Think SAFETY - email signature
Cardiac Rehab Service SOP (S109)
This SOP was drawn up to confirm and clarify the operating procedure for the community cardiac rehabilitation service (CR) This document sets out the standards which, in the view of the patient and professional organisations involved, are required of services to deliver a high-quality community cardiac rehabilitation service for people with cardiovascular disease (CVD) Cardiac rehabilitation is a comprehensive secondary prevention programme of exercise and education aimed at people who have had a cardiac event, cardiac surgery, and heart failure. Research has demonstrated that it helps reduce mortality and morbidity “The evidence base that supports the merits of comprehensive CR is robust and consistently demonstrates a favourable impact on cardiovascular mortality and hospital re-admissions in patients with coronary heart disease” (Anderson et al 2016). The community cardiac rehabilitation service was developed in response to a growing need for more cardiac rehabilitation programmes for a wider range of cardiac conditions which were unable to be accommodated in the acute hospital programmes and to offer a menu of options for delivery of programmes closer to the patient’s own home.
NatPSA-2023-010-MHRA
APPENDIX 4 Application for Adoption Leave and Pay Form.docx
Organisational strategy - Bitesize slides - Healthy Communities.pptx
Organisational strategy - Bitesize slides - Healthy Communities.pptx
Trust Policy for Free of Charge (FOC) Medicines Schemes (P109)
This policy is to ensure consistent, equitable and robust consideration of any free of charge (FOC) scheme that DCHS clinicians would like to be considered for use within DCHS, in line with the National guidance on FOC schemes. Including the requirement for consideration of schemes within Derbyshire for system approval prior to use within DCHS by the Derbyshire Joint Area Prescribing Committee. Where the medicine is currently commissioned by NHS England Specialised Commissioning, ICSs should discuss all FOC schemes with their regional specialised commissioning team in the first instance, before a decision is made on whether to implement the FOC scheme.